iRhythm Holdings (IRTC) FCF Margin Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -80.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 473.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 23.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -431.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1,716.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,811.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2,833.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 192.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 261.00 |
| 10 | iRhythm Holdings | 3.55 Bn | 3.00 Bn | 141.35 Mn | -934.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -934.00 |
| Dec 31, 2025 | -60.00 |
| Sep 30, 2025 | 1,210.00 |
| Jun 30, 2025 | -1,016.00 |
| Mar 31, 2025 | 4,179.00 |
| Dec 31, 2024 | 5,003.00 |
| Sep 30, 2024 | -268.00 |
| Jun 30, 2024 | 1,143.00 |
| Mar 31, 2024 | -1,169.00 |
| Dec 31, 2023 | -7,371.00 |
| Sep 30, 2023 | 354.00 |
| Jun 30, 2023 | 1,923.00 |
| Mar 31, 2023 | 718.00 |
| Dec 31, 2022 | 5,282.00 |
| Sep 30, 2022 | -768.00 |
| Jun 30, 2022 | -826.00 |
| Mar 31, 2022 | 1,964.00 |
| Dec 31, 2021 | -2,852.00 |
| Sep 30, 2021 | -231.00 |
| Jun 30, 2021 | 1,629.00 |
| Mar 31, 2021 | -2,141.00 |
| Dec 31, 2020 | 3,514.00 |
| Sep 30, 2020 | 1,515.00 |
| Jun 30, 2020 | -1,938.00 |
| Mar 31, 2020 | -153.00 |
| Dec 31, 2019 | -1,418.00 |
| Sep 30, 2019 | 933.00 |
| Jun 30, 2019 | 1,633.00 |
| Mar 31, 2019 | 620.00 |
| Dec 31, 2018 | 240.00 |
| Sep 30, 2018 | 19.00 |
| Jun 30, 2018 | -1,304.00 |
| Mar 31, 2018 | -991.00 |
| Dec 31, 2017 | -639.00 |
| Sep 30, 2017 | 123.00 |
| Jun 30, 2017 | 1,908.00 |
| Mar 31, 2017 | 4,361.00 |
| Dec 31, 2016 | 4,391.00 |